Semax (10 mg Vial) Dosage Protocol

Dosing & Reconstitution Overview

Semax is a synthetic heptapeptide modelled on the ACTH(4–10) fragment, extended with a C-terminal Pro-Gly-Pro sequence that slows enzymatic breakdown. The figures below are compiled strictly for laboratory and educational reference — they describe how the compound has been handled and dosed across published research, not a recommendation for use in humans or animals.

For a 10 mg vial, adding 3.0 mL of bacteriostatic water yields a concentration of roughly 3.33 mg/mL (about 3,333 mcg/mL). At that fill, each 0.10 mL drawn on a U-100 insulin syringe equals 10 units and delivers approximately 333 mcg of material, so a 300 mcg measurement sits near the 9-unit mark and the titration steps stay easy to read.

Although much of the clinical Semax literature describes intranasal delivery, the protocol modelled here follows the subcutaneous reconstitution format common to research-vial measurement work. The mg/mL math is identical regardless of the route studied.

Standard (Gradual) Titration Schedule

The gradual schedule steps the daily amount upward roughly every two weeks, mirroring the slow-escalation approach used to establish tolerability before reaching the upper end of the studied range.

Reconstitution Steps

1. Let the sealed lyophilized vial and the bacteriostatic water reach room temperature, then wipe both stoppers with an alcohol swab.
2. Draw 3.0 mL of bacteriostatic water and inject it slowly down the inside wall of the vial — never directly onto the powder pellet.
3. Roll or swirl gently until fully dissolved. Do not shake; vigorous agitation can degrade the peptide.
4. The solution should be clear and colourless. Label the vial with the concentration (~3.33 mg/mL) and the reconstitution date.
5. Store upright under refrigeration between uses, protect from light, and draw subsequent volumes with a fresh sterile syringe each time.

Advanced (Aggressive) Titration Schedule

The advanced schedule compresses the escalation, reaching the upper studied band of the range more quickly. It is presented only as a faster-modelling variant of the same dose ceiling, not a higher one.

Supplies Needed

• Semax vials (10 mg): ~4 vials for an 8-week run; ~6 vials for 12 weeks; ~8 vials for a 16-week schedule.
• Insulin syringes (U-100, 1 mL): ~56 for 8 weeks, ~84 for 12 weeks, ~112 for 16 weeks — one fresh syringe per daily draw.
• Bacteriostatic water (10 mL): two bottles cover an 8–12 week schedule; three bottles for a 16-week run.
• Alcohol swabs: two 100-count boxes for 8–12 weeks; a third box for 16 weeks.

Protocol Overview

• Research goal: model cognitive, attentional and neuroprotective effects via ACTH(4–10) analog activity.
• Schedule: once-daily administration in the modelled protocol.
• Dose band: 300–800 mcg daily.
• Fill: 10 mg lyophilized, reconstituted to ~3.33 mg/mL with 3 mL diluent.
• Storage: −20 °C dry; 2–8 °C once reconstituted.

Dosing Protocol Notes

• Begin at the lowest 300 mcg step and hold each level for about two weeks before escalating.
• Keep administration on a fixed daily cadence and a consistent time of day for steady exposure modelling.
• Escalate only after tolerability is established at the prior step.
• Cycling the compound — periods on followed by a break — is common in the educational literature rather than indefinite continuous use.

Storage Instructions

Keep sealed lyophilized vials at −20 °C, in dry and dark conditions, where stability extends for many months. Once reconstituted, refrigerate at 2–8 °C (about 36–46 °F) and use within roughly 30 days. Protect the solution from light at all times, allow refrigerated material to warm slightly before drawing, and avoid repeated freeze-thaw cycles, which can shorten usable life.

Important Handling Notes

• Use a sterile syringe for every draw and never re-enter the vial with a used needle.
• Wrap the vial in foil or keep it in an opaque container, since the peptide is light-sensitive.
• Allow vials to reach room temperature before opening to limit condensation inside the stopper.
• Document each draw — date, volume, remaining material — for reproducibility.

How Semax Works

Semax is a synthetic analog of the ACTH(4–10) fragment, joined to a C-terminal Pro-Gly-Pro tripeptide that resists rapid enzymatic cleavage. Research describes it as modulating brain-derived neurotrophic factor (BDNF) expression and influencing cholinergic and dopaminergic neurotransmission, alongside reported neuroprotective and antioxidant activity. Importantly, it carries the ACTH backbone without driving the corticosteroid response, so studies report no meaningful rise in cortisol. This combination is what positions it in the literature as a nootropic and neuroprotective peptide rather than a hormone analog.

Reported Benefits & Side Effects

Benefits observed in research

• Support for attention, memory consolidation and learning, particularly in populations with cognitive deficits.
• Studied in ischemic stroke and traumatic brain injury contexts with favourable safety signals.
• Examined in optic neuropathy work with reported neuroprotective effects.
• Generally favourable safety profiles across month-long human trials.

Side effects reported

• Generally well tolerated across the studied routes.
• Intranasal delivery may cause minor nasal irritation; subcutaneous administration may produce mild injection-site reactions such as redness or itching.
• No significant elevations in cortisol or other adverse endocrine effects reported in clinical studies.

Supporting Lifestyle Factors (Research Context)

• Consistent sleep, since memory consolidation outcomes in the cognitive literature depend heavily on rest.
• Cognitive engagement — learning tasks and structured mental activity — as the backdrop against which nootropic effects are measured.
• Adequate hydration and stable nutrition as standard study controls.

Injection / Handling Technique (Reference Only)

• Prepare the vial and site with alcohol swabs and let them dry.
• Insert subcutaneously at a 45–90° angle depending on needle length, into abdomen, thigh or upper-arm tissue; aspiration is not required for subcutaneous work.
• Inject slowly and rotate sites systematically, keeping draws at least 1–2 inches apart.
• Dispose of sharps in an approved container after a single use.

References

Related Protocols